BioMérieux: Clinical Trials

67 trials sponsored by BioMérieux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

42 completed, 8 recruiting, 8 unknown, 6 terminated. 35 Not applicable, 2 Phase 3, 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable35Completed 22, Recruiting 5, Terminated 3, Not yet recruiting 2, Unknown 2, Active not recruiting 1
Phase 32Completed 1, Unknown 1
Phase 42Completed 1, Terminated 1
Phase 21Terminated 1

Follow BioMérieux: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)
PCR multiplex BioFire Pneumonia plus - VAP - Ventilator Associated Pneumonia, Antibiotic
Not applicableNot yet recruitingUniversity Hospital, Geneva1702026-06-052026-04-29
Impact of BioFire FilmArray Pneumonia Panel vs Routine Diagnostics on Antimicrobial Outcomes (DOOR-MAT)
Multiplex PCR-based pneumonia panel (BIOFIRE® FILMARRAY® Pneumonia Panel) - Pneumonia - Bacterial
Not applicableRecruitingHospital de Clinicas de Porto Alegre1502026-05-202026-09-17
Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.
Biofire FilmArray Meningitis/Encephalitis Panel - Meningitis, Encephalitic Infection
Not applicableRecruitingFederal University of Health Science of Porto Alegre1822026-04-132026-08-21
The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
Diagnostic Test: Rapid Antimicrobial Susceptibility Testing (R-AST) guided Stewardship, Standard of Care (SOC) - Bloodstream Infection, Gram-Negative Infections
Not applicableRecruitingIstituto Clinico Humanitas4002026-03-192026-06-24
Clinical Assessment of Respiratory Events for Kids: Integrating Diagnostics and Stewardship
SPOTFIRE R - Respiratory Tract Infections (RTI), Influenza-like Illness
Not applicableNot yet recruitingBioMérieux7202026-03-012026-03-06
Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial
SPOTFIRE R/ST Diagnostic Test - Acute Respiratory Infections (ARIs)
Not applicableCompletedBioMérieux8002025-12-222026-10-19
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
TTV DNAemia, EQ-5D-5L questionnaire, Biological tests - Infection, Cancer
Not applicableRecruitingHospices Civils de Lyon6002025-04-232026-05-27
SPOTFIRE Sore Throat (ST) Study
SPOTFIRE ST System - Pharyngitis, Infective
Not applicableCompletedUniversity of Wisconsin, Madison2002024-12-022026-03-23
VIDAS® TBI Real Life Performance in Subjects With Mild Traumatic Brain Injury (mTBI)
VIDAS® TBI Test [GFAP and UCH-L1 assays] - Mild Traumatic Brain Injury
Not applicableCompletedBioMérieux9032024-05-162026-03-06
Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries
UCH-L1 GFAP - Traumatic Brain Injury
RecruitingCentre Hospitalier Princesse Grace15002024-04-192025-02-19
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
SPOTFIRE R Panel - Acute Respiratory Infection, Viral Infection
Not applicableActive not recruitingChristopher Payette2002024-03-122025-11-21
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Reveal - Gram-negative Bacteremia, Bloodstream Infection
Not applicableCompletedDuke University8992023-12-222026-07-28
LUNG INFECTION in ICU (LUNG-I3)
VAP - Ventilator Associated Pneumonia
RecruitingBioMérieux682023-12-052025-02-12
VIDAS® NEPHROCLEAR Reference Interval Study
Diagnostic Test: VIDAS® NEPHROCLEAR™ CCL14 Test - Healthy
CompletedBioMérieux5852023-07-182024-02-28
VIDAS® NEPHROCLEAR Diagnostic Accuracy Study
VIDAS® NEPHROCLEAR™ CCL14 Test - Acute Kidney Injury, Stage 2 Acute Kidney Injury
CompletedBioMérieux4772023-07-172024-02-28
Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa
VIDAS® Dengue Antigen NS1, VIDAS® Anti-Dengue IgM, VIDAS® Anti-Dengue IgG, VIDAS® Anti-Chikungunya IgM and VIDAS® Anti-Chikungunya IgG, Standard of care practices - Dengue, Chikungunya
Not applicableCompletedBioMérieux8042023-06-012025-02-11
Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay
Respiratory Panel PCR Sputum - Respiratory Infection
Not applicableUnknownAlexander Zoufaly3022023-05-102023-07-03
Molecular Early Sepsis Identification Study
Septicyte Rapid ®, FilmArray® blood culture identification (BCID2®) - Sepsis, Molecular Diagnosis
UnknownAlejandro Rodriguez Oviedo , MD1202023-04-122023-05-03
Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU
Innovative diagnostic technologies, Reference diagnostic technique - Bacteremia
Not applicableCompletedCentre Hospitalier Universitaire de Nīmes1002023-03-082026-09-16
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
Personalized antibiotic treatment, Usual antibiotic treatment - Acute Exacerbation of COPD
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris2042022-12-082025-06-25

Showing 20 of 67. Sign in to see all of them.

Conditions studied

Sepsis (11)  ·  Infections (7)  ·  Respiratory Tract Infections (7)  ·  Disease (6)  ·  Pneumonia (6)  ·  Acute Kidney Injury (5)  ·  Shock, Septic (5)  ·  Community-Acquired Pneumonia (4)  ·  Emergencies (3)  ·  Pneumonia, Ventilator-Associated (3)  ·  Virus Diseases (3)  ·  Bacteremia (2)  ·  Brain Concussion (2)  ·  COVID-19 (2)  ·  Carcinoma, Hepatocellular (2)

Interventions

Blood Specimen Collection (3)  ·  Procalcitonin (2)  ·  Rapid Diagnostic Tests (2)  ·  Standard of Care (2)  ·  Anesthesia, Spinal (1)  ·  Anesthetics, General (1)  ·  Cardiac Surgical Procedures (1)  ·  Clinical Decision Rules (1)  ·  Diagnosis (1)  ·  Emapalumab (1)  ·  Enzyme-Linked Immunosorbent Assay (1)  ·  Interferon-gamma (1)  ·  Probiotics (1)  ·  Surveys and Questionnaires (1)

Countries

France (24)  ·  United States (15)  ·  Belgium (8)  ·  Switzerland (6)  ·  United Kingdom (6)  ·  Germany (5)  ·  Spain (5)  ·  Brazil (4)  ·  Canada (4)  ·  India (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Greece (3)  ·  Australia (2)  ·  Israel (2)

Top investigators

Julie Bottero, MD (2)  ·  Alessandro C Pasqualotto, PhD (1)  ·  Alexander Lepak, MD (1)  ·  Alexander Zoufaly, Prof. Dr. (1)  ·  Alix Pantel (1)  ·  Amanda Lopes (1)  ·  Andrea Prinzi, PhD (1)  ·  Andrew Meltzer, MD (1)  ·  Ashvind Prabahran, Dr (1)  ·  Charles Daley (1)

Results publications

PMID 20097417, PMID 21030489, PMID 21336114, PMID 21936959, PMID 22302662, PMID 22878115, PMID 24669841, PMID 25005339, PMID 25503770, PMID 26668814, PMID 26954517, PMID 27429538, PMID 28314711, PMID 28637738, PMID 28851296, PMID 29781385, PMID 30623693, PMID 30772864, PMID 31229593, PMID 32709653, PMID 33395094, PMID 33927121, PMID 33980648, PMID 34036552, PMID 34534131, PMID 34795661, PMID 34912347, PMID 35148542, PMID 35211796, PMID 35246776, PMID 35418412, PMID 36301921, PMID 36509812, PMID 36658543, PMID 36917594, PMID 36972972, PMID 37460257, PMID 37597512, PMID 37940357, PMID 38670622, PMID 38837680, PMID 39052715, PMID 39072240, PMID 39111697, PMID 39352692, PMID 39535868, PMID 40754712, PMID 41225518, PMID 41242333, PMID 41323957

NIH funding

2009 (1), R01GM101197 (1), UM1AI104681 (1)